Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

Biological Psychiatry

Volumn 70, Issue 2, 2011, Pages 145-151

  Schneider, Philine ^a   Buerger, Katharina ^a,i   Teipel, Stefan ^b,c   Uspenskaya, Olga ^a,g   Hartmann, Oliver ^d   Hansson, Oskar ^h   Minthon, Lennart ^h   Rujescu, Dan ^a   Moeller, Hans Juergen ^a   Zetterberg, Henrik ⁱ   Blennow, Kaj ^a,i   Ernst, Andrea ^d   Bergmann, Andreas ^e   Hampel, Harald ^a,f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d Research Department   (Germany)

^e Waltraut Bergmann Foundation   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^h LUND UNIVERSITY   (Sweden)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alzheimer's disease; antihypertensive therapy; antihypertensive treatment; microcirculatory function; mild cognitive impairment; MR proANP

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MIDREGIONAL PROATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 79959744308     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.01.036     Document Type: Article

References (49)

1. J.C. de la Torre Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics Lancet Neurol 3 2004 184 190 (Pubitemid 38232669)
2. R.N. Kalaria The role of cerebral ischemia in Alzheimer's disease Neurobiol Aging 21 2000 321 330 (Pubitemid 30387091)
3. H. Chertkow, F. Massoud, Z. Nasreddine, S. Belleville, Y. Joanette, and C. Bocti Diagnosis and treatment of dementia: 3 Mild cognitive impairment and cognitive impairment without dementia CMAJ 178 2008 1273 1285 (Pubitemid 351678349)
4. T. Matsui, M. Nemoto, M. Maruyama, T. Yuzuriha, H. Yao, and H. Tanji Plasma homocysteine and risk of coexisting silent brain infarction in Alzheimer's disease Neurodegener Dis 2 2005 299 304
5. C. Patterson, J.W. Feightner, A. Garcia, G.Y. Hsiung, C. MacKnight, and A.D. Sadovnick Diagnosis and treatment of dementia: 1 Risk assessment and primary prevention of Alzheimer disease CMAJ 178 2008 548 556 (Pubitemid 351413998)
6. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141 1145 (Pubitemid 126512042)
7. M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt, and B. Winblad Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease Arch Neurol 62 2005 1556 1560 (Pubitemid 41434560)
8. E.B. Larson, L. Wang, J.D. Bowen, W.C. McCormick, L. Teri, P. Crane, and W. Kukull Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older Ann Intern Med 144 2006 73 81 (Pubitemid 46768225)
9. S. Gauthier, B. Reisberg, M. Zaudig, R.C. Petersen, K. Ritchie, and K. Broich Mild cognitive impairment Lancet 367 2006 1262 1270
10. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: Clinical characterization and outcome Arch Neurol 56 1999 303 308 (Pubitemid 29120227)
11. M.C. Tierney, J.P. Szalai, W.G. Snow, R.H. Fisher, A. Nores, and G. Nadon Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study Neurology 46 1996 661 665 (Pubitemid 26099629)
12. S. Bombois, S. Debette, A. Bruandet, X. Delbeuck, C. Delmaire, D. Leys, and F. Pasquier Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients Stroke 39 2008 2046 2051
13. P. Forti, F. Maioli, N. Pisacane, E. Rietti, F. Montesi, and G. Ravaglia Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI) Arch Gerontol Geriatr 44 suppl 1 2007 155 165
14. C. Regan, C. Katona, Z. Walker, J. Hooper, J. Donovan, and G. Livingston Relationship of vascular risk to the progression of Alzheimer disease Neurology 67 2006 1357 1362 (Pubitemid 44632057)
15. A. Heyman, G.G. Fillenbaum, K.A. Welsh-Bohmer, M. Gearing, S.S. Mirra, and R.C. Mohs Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII Consortium to Establish a Registry for Alzheimer's Disease Neurology 51 1998 159 162 (Pubitemid 28345377)
16. R.N. Kalaria Cerebral vessels in ageing and Alzheimer's disease Pharmacol Ther 72 1996 193 214 (Pubitemid 26425810)
17. H.V. Vinters Cerebral amyloid angiopathy A critical review Stroke 18 1987 311 324 (Pubitemid 17059655)
18. J.M. Olichney, L.A. Hansen, D. Galasko, T. Saitoh, C.R. Hofstetter, R. Katzman, and L.J. Thal The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant Neurology 47 1996 190 196 (Pubitemid 26243882)
19. D.R. Premkumar, D.L. Cohen, P. Hedera, R.P. Friedland, and R.N. Kalaria Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease Am J Pathol 148 1996 2083 2095
20. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and the clinical expression of Alzheimer disease The Nun Study JAMA 277 1997 813 817 (Pubitemid 27111317)
21. C. Qiu, B. Winblad, and L. Fratiglioni The age-dependent relation of blood pressure to cognitive function and dementia Lancet Neurol 4 2005 487 499 (Pubitemid 40982459)
22. W.B. Applegate, S. Pressel, J. Wittes, J. Luhr, R.B. Shekelle, and G.H. Camel Impact of the treatment of isolated systolic hypertension on behavioral variables Results from the systolic hypertension in the elderly program Arch Intern Med 154 1994 2154 2160 (Pubitemid 24317261)
23. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, W.H. Birkenhager, and M.R. Babarskiene Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial Lancet 352 1998 1347 1351 (Pubitemid 28510916)
24. C. Tzourio, C. Anderson, N. Chapman, M. Woodward, B. Neal, S. MacMahon, and J. Chalmers Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch Intern Med 163 2003 1069 1075 (Pubitemid 36548935)
25. I. Skoog, H. Lithell, L. Hansson, D. Elmfeldt, A. Hofman, and B. Olofsson Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) Am J Hypertens 18 2005 1052 1059 (Pubitemid 41139903)
26. R. Peters, N. Beckett, F. Forette, J. Tuomilehto, R. Clarke, and C. Ritchie Incident dementia and blood pressure lowering in the hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial Lancet Neurol 7 2008 683 689
27. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 2010 131 144
28. H. Hampel, R. Frank, K. Broich, S.J. Teipel, R.G. Katz, and J. Hardy Biomarkers for Alzheimer's disease: Academic, industry and regulatory perspectives Nat Rev Drug Discov 9 2010 560 574
29. T. Zetzsche, D. Rujescu, J. Hardy, and H. Hampel Advances and perspectives from genetic research: Development of biological markers in Alzheimer's disease Expert Rev Mol Diagn 10 2010 667 690
30. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 50 2004 234 236 (Pubitemid 38125732)
31. M. Khaleghi, U. Saleem, N.G. Morgenthaler, S.T. Turner, A. Bergmann, and J. Struck Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension Am J Hypertens 22 2009 425 431
32. K. Buerger, A. Ernst, M. Ewers, O. Uspenskaya, M. Omerovic, and N.G. Morgenthaler Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio Biol Psychiatry 65 2009 979 984
33. K. Buerger, O. Uspenskaya, O. Hartmann, O. Hansson, L. Minthon, and K. Blennow Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: A retrospective analysis of 134 patients with mild cognitive impairment [published online ahead of print November 2] J Clin Psychiatry 2010
34. O. Hansson, H. Zetterberg, P. Buchhave, E. Londos, K. Blennow, and L. Minthon Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study Lancet Neurol 5 2006 228 234 (Pubitemid 43238346)
35. M. Potocki, T. Breidthardt, T. Reichlin, S. Hartwiger, N.G. Morgenthaler, and A. Bergmann Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure J Intern Med 267 2009 119 129
36. K. Nakao, Y. Ogawa, S. Suga, and H. Imura Molecular biology and biochemistry of the natriuretic peptide system II: Natriuretic peptide receptors J Hypertens 10 1992 1111 1114
37. K. Nakao, Y. Ogawa, S. Suga, and H. Imura Molecular biology and biochemistry of the natriuretic peptide system I: Natriuretic peptides J Hypertens 10 1992 907 912
38. H.H. Chen, and J.C. Burnett Natriuretic peptides in the pathophysiology of congestive heart failure Curr Cardiol Rep 2 2000 198 205
39. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368 (Pubitemid 50011582)
40. P. Knaapen, T. Germans, P.G. Camici, O.E. Rimoldi, F.J. ten Cate, and J.M. ten Berg Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol 294 2008 H986 H993
41. S. Beer, S. Golay, D. Bardy, F. Feihl, R.C. Gaillard, and C. Bachmann Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications Diabetes Metab 31 2005 567 573 (Pubitemid 43001174)
42. S. Del Ry, D. Giannessi, M. Maltinti, C. Prontera, A. Iervasi, and C. Colotti Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction Peptides 28 2007 1068 1073 (Pubitemid 46654449)
43. J. Gunstad, A. Poppas, S. Smeal, R.H. Paul, D.F. Tate, and A.L. Jefferson Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease Am J Cardiol 98 2006 538 540 (Pubitemid 44162885)
44. M. Feola, G.L. Rosso, M. Peano, M. Agostini, N. Aspromonte, and G. Carena Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure Arch Med Res 38 2007 234 239 (Pubitemid 46080551)
45. L.J. Launer, G.W. Ross, H. Petrovitch, K. Masaki, D. Foley, L.R. White, and R.J. Havlik Midlife blood pressure and dementia: The Honolulu-Asia aging study Neurobiol Aging 21 2000 49 55 (Pubitemid 30224785)
46. I. Skoog, and D. Gustafson Update on hypertension and Alzheimer's disease Neurol Res 28 2006 605 611 (Pubitemid 44444422)
47. O. Hanon, R. Pequignot, M.L. Seux, H. Lenoir, A. Bune, and A.S. Rigaud Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints J Hypertens 24 2006 2101 2107 (Pubitemid 44371278)
48. H. Hanyu, K. Hirao, S. Shimizu, T. Iwamoto, K. Koizumi, and K. Abe Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment Nucl Med Commun 28 2007 281 287 (Pubitemid 46673205)
49. N.C. Li, A. Lee, R.A. Whitmer, M. Kivipelto, E. Lawler, L.E. Kazis, and B. Wolozin Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis BMJ 340 2010 b5465